Morphosis Capital and Romanian Entrepreneur Launch PRIMIA MEDICAL to Consolidate Women’s Health Services Across Romania

Morphosis Capital Fund II and entrepreneur George Peltecu created PRIMIA MEDICAL, a new private network that unites fertility specialist Umana Fertility and the Royal Hospital to provide comprehensive women’s health services, with plans to grow across Romania through a buy‑and‑build strategy.

Romanian High School Students Win Innovation Prize with AI App for Speech Disorders

Six Romanian high‑school students created Grai, an AI‑driven mobile app that combines voice recognition with lip‑movement analysis to help people with dysarthria communicate. Guided by mentors from Wolfpack Digital, they trained the AI models on 800 recordings and won the top prize at the 2026 Academia DpIT competition. The team plans to further develop the app and enter additional innovation contests.

VectorY Therapeutics Secures €74.5 Million to Accelerate ALS and Huntington’s Disease Programmes

Amsterdam‑based VectorY Therapeutics, a biotech developing vectorised antibody therapies for neurodegenerative diseases, closed a €74.5 million financing round with participation from new and existing investors. The funds will be used to push its lead ALS programme forward and expand its pipeline into Huntington’s disease and other conditions.

Italian Biotech DNAswitch Secures €500,000 from BioInnovation Institute for Gene Therapy Development

Italian biotech spin‑off DNAswitch, founded in 2024 and based in Padova, secured €500,000 from the BioInnovation Institute’s Catalyst Fund for Italy, marking the first Italian company to receive support from BII’s International Venture Lab. The funding will accelerate its novel gene‑therapy approach for Huntington’s disease, which activates the transcription factor MTF1 to trigger endogenous neuronal defence mechanisms.

Romanian Dental Startup Expands with 300,000-Lei Loan from Banca Transilvania

Adrian Jilcu, former banking professional, launched Avalon Dental Clinic in 2023. After initial success, he obtained a 300,000‑lei loan from Banca Transilvania’s BT Mic program and leveraged the BT Stup entrepreneurship hub for networking and supplier connections, enabling the opening of a second clinic in Bucharest and plans for further expansion across Romania.

London-based Orakl Oncology secures $34 million to advance AI-powered virtual patient platform for cancer drug testing

Orakl Oncology, a UK‑based healthtech startup, secured $34 million in funding to advance its AI platform that generates virtual patients for cancer‑drug testing, aiming to speed up drug development and reduce reliance on animal studies.

Czech Medtech Startup Kardi Ai Secures €5.3 Million Series A to Expand ECG Monitoring Platform Across Europe and Asia

Czech medtech startup Kardi Ai secured €5.3 million in Series A financing led by Callisto Health to scale its long‑term ECG monitoring platform, expand into new European markets and launch in Asia, and develop AI‑driven predictive heart‑arrhythmia models.

Helsinki-based Switchpoint Bio Raises €4.75 Million to Develop Blood-Based Epigenomic Platform for Drug Development

Switchpoint Bio, a Helsinki‑based TechBio startup, emerged from stealth and secured €4.75 million in pre‑seed funding led by Treehouse Delmar Investments to advance its blood‑based epigenomic platform that aims to give drug developers a scalable view of disease and treatment effects.